Clinical distribution and surveillance of drug resistance on Acinetobacter baumannii infection

Objective:To investigate the clinical distribution and the drug resistance of Acinetobacter baumannii to provide guidance for clinical medication.Methods:Specimens were collected from clinical patients with infection from January 2006 to December 2008,Acinetobacter baumannii were isolated and the drug sensitivity tested retrospectively.Results:A total of 472 cases of Acinetobacter baumannii were isolated,sputum was the main specimen of which Acinetobacter baumannii were isolated(70.34%),Acinetobacter baumannii was mainly distributed at ICU(32.84%).These strains were susceptible to imipenem,meropenem and cefoperazone/sulbactam,the drug resistance rate to other eleven antibiotics was high.Conclusion:Acinetobacter baumannii is susceptible to imipenem,meropenem and cefoperazone/sulbactam and antimicrobial agents should be used rationally to decrease multi-drug resistance.